| Literature DB >> 25828724 |
Alban Denys1, Marc Pracht, Rafael Duran, Boris Guiu, Salim Adib, Ariane Boubaker, Pierre Bize.
Abstract
Transarterial radioembolization consist in delivering small particles loaded with Yttrium90, a pure beta emitter, in order to treat primary and secondary liver tumors. This treatment needs precaution since inadequate delivery of these beads can lead to severe complications. Moreover, a precise radiation dosing is crucial to achieve a good clinical success and to avoid complications such as radioembolization-induced liver disease. This review describes all the precautions and highlights clinical and technical considerations that need to be taken to avoid complications.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25828724 DOI: 10.1007/s00270-015-1071-x
Source DB: PubMed Journal: Cardiovasc Intervent Radiol ISSN: 0174-1551 Impact factor: 2.740